FDA Investigator Eboni S Funderburk
Eboni S Funderburk has conducted inspections on 14 sites in 1 countries as of 23 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
23 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Eboni S Funderburk:
Alan L Truong,
Anastasia M Shields,
Andrew J Barrowcliff,
Bei Y He,
Benjamin J Smith,
Brian D Nicholson,
Bruce H Mccullough,
Carl A Huffman, III,
Charles Yuanchia Kuo, PhD,
Christopher D Leach,
Cristina Ausin Moreno, PhD,
Daniel J Gorski,
David Perkins,
Debra I Love,
Denise M Digiulio,
Diane L Raccasi,
Edwin Jao,
Elizabeth L Philpy,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Esther C Broner, PhD,
Geneve M Maxwell,
Geneve M Parks,
Hyung Yul Lee,
Jacob G Lutz,
James A Lane,
Jeffrey A Sommers,
Jeffrey D Meng,
Jon P Antoniou,
Joshua M Adams,
Joshua P Wireman,
Joslyn K Brunelle, PhD,
Kshitij A Patkar,
Larry K Austin,
Laurie A Haxel,
LCDR Sean Byrd,
Lequita M Mayhew,
Lewis K Antwi,
Logan T Williams,
Maria Cruz Fisher,
Mark G Peterson,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Michele Perry Williams,
Muna Algharibeh,
Neal D Singletary, PhD,
Nicholas L Paulin,
Nicholas P Diorio,
Paranthaman Senthamaraikannan,
Patrick C Klotzbuecher,
Patsy J Domingo,
Phung Thien Nguyen,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Robert Barbosa,
Robert M Barbosa,
Ross J Grigsby,
Russell K Riley,
Samina S Khan,
Sandra A Boyd,
Sandra A Hughes,
Sargum C Sood,
Scott R Nichols, PhD,
Sneha S Patel,
Steven P Eastham,
Susan D Yuscius,
Susan P Bruederle,
Thomas J Arista,
Timothy J Schmidt,
Vaishali J Patel,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yuan Chia Kuo,
Yvonne E Lozano
Eboni S Funderburk's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2021 | EIR | Sentry BioPharma Services - EIR, 2021-06-29 |
September, 2022 | FDA 483 | Catalent Indiana, LLC - Form 483, 2022-09-01 |
April, 2023 | FDA 483 | Vintage Chemical Inc - Form 483, 2023-04-12 |
November, 2023 | FDA 483 | Vintage Chemical Inc - Form 483, 2023-11-20 |
April, 2022 | EIR | Rising Pharma Holdings, Inc. - EIR, 2022-04-08 |
September, 2022 | EIR | Catalent Indiana, LLC - EIR, 2022-09-01 |
February, 2024 | FDA 483 | Enzyme Solutions, Inc. - Form 483, 2024-02-23 |
August, 2021 | FDA 483 | Ceela Naturals - Form 483, 2021-08-31 |
April, 2022 | FDA 483 | Rising Pharma Holdings, Inc. - Form 483, 2022-04-08 |
March, 2022 | FDA 483 | MD Logistics, LLC - Form 483, 2022-03-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more